COMPANY

Harlingene Life Sciences LLC

HQ: Doylestown, PA source

Location: Doylestown, PA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $1M (STTR Phase II 5R42AI177204-04, continuation, notice Aug 18, 2026). NIH RePORTER 5R42AI177204-04 (Aug 18, 2026)
Evidence (1 event)
- Aug 18, 2026 · NIH RePORTER 5R42AI177204-04
  Organization: HARLINGENE LIFE SCIENCES LLC; City/State: DOYLESTOWN, PA; Project number: 5R42AI177204-04; Activity code: R42; Fiscal year: 2026; Award notice date: 2026-08-18; FY total cost (award amount): 1000000; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Hepatoselective Dihydrozuinolizone (HS-DHQ) Molecules for Treatment and Prevention of Hepatitis A Virus (HAV) Infection; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals